+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 32696

Chapter 32696 contains a list of PDF Full Texts available from EurekaMag.

Nordstrom, B.; Strang, P.; Bergstrom, R.; Nilsson, S.; Tribukait, B., 1997:
P53, Ki-67 and flow cytometric S-phase as predictors of survivals in endometrial carcinoma

Suliman, M.E.; Royds, J.A.; Timperley, W.R.; Cullen, D.R.; Jones, T.H., 1998:
P53, MDM2 and P21 protein expression in pituitary adenomas, an immunocytochemical study on paraffin-embedded tissue

Vielh, P.; Pouillart, P.; Klijanienko, J.; Fourquet, A.; Chevillard, S., 1998:
P53, MDR1 and SPF prognostic relevance in breast cancer

O'reilly, P.E.; Raab, S.S.; Niemann, T.H.; Robinson, R.A., 1995:
P53, PCNA and KI-67 expression in extrauterine leiomyosarcomas

Allison, R.T.; Best, T., 1998:
p53, PCNA and Ki-67 expression in oral squamous cell carcinomas: the vagaries of fixation and microwave enhancement of immunocytochemistry

Okamura, T.; Akita, H.; Ueda, K.; Kohri, K., 1997:
P53, PCNA and bcl-2 immunohistochemical evaluation of BCG intravesical instillation therapy for superficial bladder cancers

Carrato, A.; O'connor, E.; Baron, J.M.; Sanchez, J.J.; Orduna, A.; Teruel, A.; Rufete, C.; Pelayo, J.M.; Diaz, N.; Barona, R., 1994:
P53, PCNA, DNA and nuclear protein analysis in human laryngeal carcinoma

Padua, R.A.; Guinn, B.; Smith, M.; West, R.; Taylor, C.; Pettersson, T.; Ridge, S.; Carter, G.; A.S.bah, A.; White, D.; Oscier, D.; Jacobs, A., 1996:
P53, RAS and FMS mutations and poor clinical outcome in myelodysplasia A 7-year follow-up

Mirjolet, J.F.; Barberi Heyob, M.; Marchal, S.; Merlin, J.L., 1998:
P53, Thymidylate synthase and G1/S checkpoint in 5-fluorouracil resistant cells

Radebold, K.; Roberts, R.; Kaye, P.V.; Isaacs, S.; Dent, D.M., 1998:
P53, Waf1, MIB1, bcl-2 as prognostic determinants in comparison to first generation prognostic factors in gastric carcinoma

Yu, J.J.; Dabholkar, M.; Vionnet, J.A.; Bostick Bruton, F.; Reed, E., 1994:
P53, XPAC, and ERCC1 expression in fresh human ovarian cancer tissues

Gisbertz, I.A.M.; Arends, J.W.; Schouten, H.C., 1994:
P53, bcl-2 and Ki-67 expression in 86 consecutive cases of gastro-intestinal non-Hodgkins lymphoma

Oxley, J.; Brewster, S.; Abbott, C.; Trivella, M.; Gillatt, D., 1998:
P53, bcl-2, E-cadherin and CD44 expression as predictors of treatment failure after radical prostatectomy

Einspahr, J.; Alberts, D.; Warnecke, J.; Hart, N.; Bozzo, P.; Quinn, J.; Grogan, T., 1997:
P53, bcl-2, and apoptosis as useful surrogate endpoint biomarkers in human skin carcinogenesis

Hsu, N.Y.; Chen, W.J.; Lin, C.C.; Chen, C.L.; Chou, F.F.; Hsieh, M.J.; Sheen Chen, S.M.; Chen, Y.S., 1998:
P53, bcl-2, and nm23 Expression in gastric cardiac carcinoma and its association with lymph node metastasis

Kastan, M.B.; Canman, C.E.; Leonard, C.J., 1995:
P53, cell cycle control and apoptosis: implications for cancer

Villaseca, M.; Araya, J.C.; Roa, I.; Roa, J.C.; Okayasu, I.; Flores, P., 1996:
P53, erbB2 p185, ras p21 and bcl-2 in gastric cancer A immunocytochemical study in a high risk population

Wang, L.; Ilic, Z.; Sell, S., 1995:
P53, mdm-2 and IGF-II in carcinogen induced hepatomas of hepatitis B virus transgenic mice

Bellini,M.F.; Leite,K.R.M.; Cury,P.M.; Silva,A.E., 2008:
P53, p16 and fhit proteins expressions in chronic esophagitis and Chagas disease

Marchetti, A.; Buttitta, F.; Pellegrini, S.; Bertacca, G.; Doglioni, C.; Barbareschi, M.; Chella, A.; Filardo, A.; Tognoni, V.; Angeletti, C.A.; Dalla Palma, P.; Bevilacqua, G., 1996:
P53, p21 and p16 in non-small cell lung carcinomas

Jimenez-Gomez,R.; Alvarez-Martinez,E.; Villarroel,M.; Montoya,S.; Alvarez,G.J.; Mosquera,Y.; Gaviria,A.M., 2008:
P53, p21WAF1/CIP1 and mdm2 expressions in oral mucosal lesions of chronic reverse and conventional smokers, from Sucre, Colombia

Mehta, R.; Kyshtoobayeva, A.; Kurosaki, T.; Small, E.; Stroop, R.; Fruehauf, J., 1997:
P53, thrombospondin-1 , angiogenesis and androgen receptor as prognostic factors in prostate cancer

Lu, L.; Coppola, D.; Yeatman, T.; Fruehauf, J.; Karl, R.; Nicosia, S., 1997:
P53,P21 TGF-beta 1 and TGF-beta 3 in ductal carcinomas of the pancreas

D.L.M.nte, S.M.; Sohn, Y.K.; Ganju, N.; Wands, J.R., 1998:
P53- and CD95-associated apoptosis and sprouting with neurodegeneration

Gasser, T.C.; Moch, H.; Sauter, G.; Richter, J.; Jiang, F.; Mihatsch, M.J., 1997:
P53- and mdm2-protein expression in renal cancer

Weinberg, W.C.; Kadiwar, N.; Azzoli, C.G.; Morgan, D.L.; Littles, S.; Yuspa, S.H., 1994:
P53-Deficiency and v-ras-Ha cooperate in malignant conversion of keratinocytes

Lue, Y.; Sinha Hikim, A.P.; Rajavashisth, T.B.; Wang, C.; Salameh, W.E.; Swerdloff, R.S., 1998:
P53-Deficiency suppresses germ cell apoptosis and stimulates cellular proliferation in vivo

Sands, A.T.; Donehower, L.A.; Bradley, A., 1993:
P53-Deficient embryonic fibroblasts exhibit decreased sensitivity to DNA damage and altered cell cycle control

Wolff, A.C.; Leonard, C.J.; Chen, C.Y.; Kastan, M.B., 1995:
P53-Dependent G-1 arrest following ionizing radiation in the absence of transcription activation

Lowe, S.W.; Ruley, H.E.rl, 1996:
P53-Dependent apoptosis in tumor progression and in cancer therapy

Dietrich, C.; Bartsch, T.; Schanz, F.; Oesch, F.; Wieser, R., 1996:
P53-Dependent cell cycle arrest induced by N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal in PDGF-stimulated human fibroblasts

Hasegawa, M.; Suzuki, Y.; Furuta, M.; Yamakawa, M.; Maebayashi, K.; Hayakawa, K.; Saito, Y.; Mitsuhashi, N.; Niibe, H., 1997:
P53-Dependent radiation-induced apoptosis in vivo Relationship to Bcl-2 and Bax expression

Schwaibold, H.; Friedrich, M.G.; Wintzer, O.; Huland, H., 1997:
P53-Expression in tumors and histologically benign looking bladder mucosa in transitional cell cancer patients A marker for recurrence?

Fan, S.; Goyal, S.; Rivet, D.I.; Bhatia, K.; Magrath, I.; Kohn, K.W.; O'connor, P.M., 1995:
P53-Gene mutations are associated with decreased sensitivity of Burkitts lymphoma cell lines to DNA damaging agents but not microtubule inhibitors

Sachs, M.; Schlechte, H.; Lenk, V.S.; Brenner, S.; Schnorr, D.; Loening, S.A., 1998:
P53-Genetic alterations as clonal markers for recurrencies of bladder cancer in urine

Ohtani-Fujita, N.; Minami, S.; Mimaki, S.; Dao, S.; Sakai, T., 1998:
p53-Independent activation of the gadd45 promoter by Delta12-prostaglandin J2

Perlman, H.R.; Walsh, K., 1997:
P53-Independent apoptosis is induced by the homeodomain protein Gax and correlates with Bax and Bad up-regulation and bcl-2 down-regulation

Lee, S.J.; Ha, M.J.; Lee, J.; Trepel, J.B., 1995:
P53-Independent induction of the cyclin-dependent kinase inhibitor p21 in prostate and breast carcinoma cells treated with an inhibitor of the HMG-CoA reductase pathway

Waga, S.; Li, R.; Stillman, B., 1997:
p53-induced p21 controls DNA replication

Matsuzawa, S.; Takayama, S.; Froesch, B.; Zapata, J.M.; Reed, J.C., 1997:
P53-Inducible human homologue of Drosophila seven in absentia inhibits cell growth and promotes apoptosis Suppression by BAG-1/HAP-1

Hall, P.A.; Meek, D.; Lane, D.P., 1996:
p53--integrating the complexity

Hursting, S.D.; Ward, J.M.; Perkins, S.N.; Haines, D.C.; Frederickson, T.; Phang, J.M., 1995:
P53-Knockout mice A model of spontaneous lymphoma for testing chemopreventive strategies

Sierra, A.; Tortola, S.; Castellsague, X.; Peinado, M.A.; Lloveras, B.; Moreno, A.; Escobedo, A.; Fabra, A., 1996:
P53-M and bcl-2 overexpression independently contribute to metastatic progression of breast cancer

Haupt, Y.; Haffner, R.; Gottlieb, E.; Rowan, S.; Oren, M., 1995:
P53-Mediated apoptosis Importance of the cellular context

Meyn, M.S.ephen; Strasfeld, L.; Allen, C., 1995:
P53-Mediated apoptosis is the primary cause of radiation sensitivity in ataxia-telangiectasia

Lin, Y.; Benchimol, S., 1997:
p53-mediated cell cycle arrest and apoptosis

Xie, M.; Alamo, I.; Zhan, Q.; Fornace, A.J.Jr, 1997:
P53-Mediated induction of the BCL-X-L mRNA by DNA strand-break agents

Mietz, J.A.; Unger, T.; Huibregtse, J.M.; Howley, P.M., 1993:
P53-Mediated transcriptional activation is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein

Kuepper, M.; Joos, S.; Bonin, F.V.; Moeller, P.; Mechterheimer, G.; Daus, H.; Pfreundschuh, M.; Lichter, P.; Truemper, L., 1998:
P53-Status in single Hodgkin and Reed Sternberg cells Allelic loss but no evidence for genomic mutations

DeLeo, A.B., 1998:
p53-based immunotherapy of cancer

Bischoff, J.R.; Wu, L., 1998:
P53-binding polypeptides and polynucleotides encoding same

Kumar, M.G.; Spandau, D.F., 1995:
P53-binding proteins in squamous cell carcinoma and normal keratinocytes

Ikawa, Y.; Tsukada, T.; Yagi, T.; Suda, Y.; Takeda, N.; Tokunaga, T.; Aizawa, S., 1993:
P53-deficient mice developed normally, and their cells were readily immortalized in vitro

Fuchs, E.J.; Mckenna, K.A.; Bedi, A., 1997:
P53-dependent DNA damage induced apoptosis requires Fas/FasL independent activation of CPP32-beta

Kelley, L.L.; Hicks, G.G.; Green, W.F.; Ruley, H.E., 1995:
P53-dependent and -independent regulation of p21 in terminally differentiating erythroblasts Distinct roles for EPO-mediated growth arrest and EPO-independent tumor suppression

Orphanidou, D.; Kalomenidis, J.; Papamichalis, G.; Rasidakis, A.; Scorilas, A.; Dimakou, K.; Viskos, A.; Sacharidou, A.; Papastamatiou, H.; Jordanoglou, J., 1998:
P53-dependent and independent p21waf-1 expression in lung cancer Correation with the smoking history of the patients

Shetty, G.; Shao, S.H.; Weng, C.C.Y., 2008:
p53-dependent apoptosis in the inhibition of spermatogonial differentiation in juvenile spermatogonial depletion (Utp14bjsd) mice

Teoh, G.; Urashima, M.; Ogata, A.; Daley, J.F.II.; Shirahama, S.; Matsuzaki, M.; Chauhan, D.; Tai, Y.T.; Treon, S.P.; Raje, N.; Hideshima, T.; Greenfield, E.A.; Nguyen, K.A.; Anderson, K.C., 1998:
P53-dependent cell cycle regulation mediated by DNA-dependent protein kinase-KU holoenzyme on the cell membrane of human multiple myeloma cell lines

Pietrzak, M.; Puzianowska-Kuznicka, M., 2008:
p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter

Cistulli, C.; Byrd, L.; Hurt, J.; Kaufmann, W., 1997:
P53-dependent signaling is required for recovery of DNA replication in UV-C-irradiated human fibroblasts

Friedrich, M.G.; Schwaibold, H.; Wintzer, O.; Soelter, J.; Huland, H., 1997:
P53-expression in histologically benign looking bladder mucosa in patients with transitional cell cancer of the bladder

He, A.W.; Cory, J.G., 1996:
P53-independent Waf1 and Gadd45 induction after DNA damage

Gerald, T.M.; Rishi, A.K.; Dawson, M.I.; Reichert, U.; Shroot, B.; FornaceA.J.Jr.; Fontana, J.A., 1997:
P53-independent enhancement of GADD45 mRNA levels in the human breast carcinoma cells exposed to a novel retinoid CD437

Shimomura, S.; Kishi, K.; Hachiya, M.; Osawa, Y.; Akashi, M., 1996:
P53-independent expression of WAF1 related to differentiation, cell death, and cell growth in human myeloid cells KY821

Chen, Y.Q.; Cipriano, S.C.; Sarkar, F.H.; Ware, J.L.; Arenkiel, J.M., 1996:
P53-independent expression of p21-WAF1 in tumor cells

Grasso, L.; Kafka, N.; Mercer, M.E., 1996:
P53-independent induction of WAF1 gene expression during differentiation of colorectal tumor cell lines

Ahmad, N.; Feyes, D.K.; Agarwal, R.; Mukhtar, H., 1997:
P53-independent induction of WAF1/Cip1/p21 regulates the cell cycle mediated apoptosis during photodynamic therapy in human epidermoid carcinoma cells A431

Bishopric, N.H.; Kaiser, S.; Discher, D.; Hernandez, O.; Zang, J.; Sato, B.; Webster, K.A., 1998:
P53-independent induction of apoptosis by hypoxia-reoxygenation of isolated cardiac myocytes

Price, P.M.; Megyesi, J.; Safirstein, R., 1997:
P53-independent induction of p21 MRNA in kidney after acute renal failure by C/EBPbeta

Yoshida, K.; Murohashi, I.; Bessho, M.; Hirashima, K., 1997:
P53-independent induction of p21 during differentiation of HL-60 cells by tumor necrosis factor alpha

Hwang, M.S.; Thompson, K.L.; Ahn, C.H., 1995:
P53-independent induction of p21-WAF1 and apoptosis by all-trans-retinoic acid and 9-cis-retinoic acid in human prostate cancer cell lines

Winthrop, M.D.; Gumerlock, P.H.; Shi, X.B.; Muenzer, J.T.; Denardo, S.J., 1997:
P53-independent tumor response in a human breast cancer xenograft following radioimmunotherapy

Xiang, H.; Kinoshita, Y.; Knudson, C.M.; Korsmeyer, S.J.; Schwartzkroin, P.A.; Morrison, R.S., 1997:
P53-induces neuronal cell death via a Bax-dependent pathway

Pellegata, N.S.; Antoniono, R.; Redpath, L.; Stanbridge, E.J., 1996:
P53-mediated G1 arrest overrides the subsequent G2 block following radiation damage

Gomez Manzano, C.; Fueyo, J.; Kyritsis, A.P.; Mcdonnell, T.J.; Marin, M.C.; Steck, P.A.; Levin, V.A.; Yung, W.K.A., 1996:
P53-mediated anticancer mechanisms in human glioma tumors Apoptosis versus growth arrest

Akhtar, A.J.; Yao, S.; Mckenna, K.A.; Bedi, G.C.; Ravi, R.; Mabry, M.; Sidransky, D.; Barber, J.P.; Armstrong, D.K.; Sharkis, S.J.; Jones, R.J.; Bedi, A., 1996:
P53-mediated apoptosis following DNA damage requires p34-cdc2 kinase

Holmes Mcnary, M.; Albright, C.D.; Zeisel, S.H., 1997:
P53-mediated cellular response to choline deficiency in rat pheochromocytoma cells

Bristow, R.; Jang, A.; Peacock, J.; Cheung, S.; Benchimol, S.; Hill, R.P., 1994:
P53-mediated radioresistance in transfected rat embryo fibroblast cells implications for radiotherapy

Chang, Esther, H., 1997:
P53-mediated tumor-targeted sensitization to chemotherapy and radiotherapy

Chen, W.; Kang, J.; Xia, J.; Li, Y.; Yang, B.; Chen, B.; Sun, W.; Song, X.; Xiang, W.; Wang, X.; Wang, F.; Wan, Y.; Bi, Z., 2008:
p53-related apoptosis resistance and tumor suppression activity in UVB-induced premature senescent human skin fibroblasts

Conner, E.A.; Wirth, P.J.; Thorgeirsson, S.S., 1998:
P53/Bax independent pathway in hepatocyte growth factor -induced apoptosis

Jones, M.W.; Hsu, C.; Kounelis, S.; Papadaki, H.; Bakker, A.; Swalsky, P.A.; Finkelstein, S.D., 1995:
P53/K-RAS-2 topographic genotyping of endometrial adenocarcinoma

Wu, T.T.; Pricolo, V.E.; Keller, G.; Glantz, L.; Bakker, A.; Swalsky, P.A.; Bland, K.I.; Finkelstein, S.D., 1995:
P53/K-Ras-2 mutation status is an independent predictor of survival in Dukes colon adenocarcinoma

Bennett, W.P.; E.D.iry, W.S.; Guinee, D.G.; Caporaso, N.E.; Welsh, J.A.; Jones, R.T.; Borkowski, A.; Travis, W.D.; Colby, T.V.; Trastek, V.; Pairolero, P.C.; Tazelaar, H.F.; Midthun, D.; Jett, J.R.; Liotta, L.A.; Vogelstein, B.; Harris, C.C., 1996:
P53/p21-wafl/cipl Expression in human lung cancer

Hansen, R.; Oren, M., 1997:
p53; from inductive signal to cellular effect

Kulesz Martin, M.F., 1998:
P53AS protein and antibody therefor

Dakouras, A.; Nikiteas, N.; Papadakis, E.; Perakis, M.; Valis, D.; Rallis, G.; Tzanakis, N.; Peros, G.; Tsigkris, C.; Kittas, C.; Karakitsos, P., 2008:
P53Arg72 homozygosity and its increased incidence in left-sided sporadic colorectal adenocarcinomas, in a Greek-Caucasian population

Bian, J.; Sun, Y., 1998:
P53CP, a putative p53 competing protein, that specifically binds to the consensus p53 DNA binding sites A third member in p53 family?

Webb, G.R.; Westacott, C.I.; Elson, C.J., 1997:
P55 TNF receptors are differentially expressed on human articular chondrocytes

Pons, S.; Torres Aleman, I.; White, M.F., 1995:
P55-PIK, a new PI3K regulatory subunit engages IGF-I signaling during central nervous system development

Yeates, L.C.; Husbeck, B.E.; Powis, G., 1998:
P55PIK, p85 and p110 phosphatidylinositol-3-kinase message levels are decreased in HT-29 cells growing as colonies in soft agarose

Taichman, R.S.; Merida, I.; Torigo, T.; Gaulton, G.N.; Reed, J.C., 1993:
P56-LCK activation by IL-2 provokes PI-3 kinase activity in T-cells

Lemasson, I.; Briant, L.; Devaux, C., 1995:
P56-lck Kinase is not obligatory for CD4 signal transduction in HTLV-I-infected T cells

Schumann, G.; Romeo, C.; Dasgupta, J.D.y, 1993:
P56-lck and ZAP-70 mediate CD 16-signaling

Collins, T.L.; Shin, J.; Strominger, J.L.; Mittler, R.S.; Burakoff, S.J., 1991:
P56l c k is required for association between cd4 and the tcr cd3 complex during t cell activation

Bertoglio, J.; Vitte Mony, I., 1993:
P56lck response to interleukin-2 in human natural killer cells

Swanger, W.J.; Roberts, J.M., 1997:
p57KIP2 targeted disruption and Beckwith-Wiedemann syndrome: is the inhibitor just a contributor?

Ostedgaard, L.S.; Zeiher, B.; Welsh, M.J., 1996:
P574H is a temperature sensitive mutant of CFTR which accumulates in a unique cytoplasmic pattern

Kochilas, L.K.; Buck, C.A.; Epstein, J.A., 1998:
P57Kip2 expression is upregulated in the embryonic mouse heart during mid-gestation and is restricted to the inner myocardial trabecular zone

Moretta, A.; Vitale, M.; Bottino, C.; Orengo, A.M.ria; Morelli, L.; Augugliaro, R.; Barbaresi, M.; Ciccone, E.; Moretta, L., 1993:
P58 molecules as putative receptors for major histocompatibility complex class I molecules in human natural killer cells Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities

Huang, J.; Carraway, K.L.; Carraway, C.A.C.rothers, 1996:
P58-gag, A membrane- and microfilament-associated protein Binding to and phosphorylation by p60-src and p120-abl in a p185-neu-containing signal transduction particle

Li, B.; Li, D.; Li, G-Gang.; Wang, H-Wen.; Yu, A-Xia., 2008:
P58(IPK) inhibition of endoplasmic reticulum stress in human retinal capillary endothelial cells in vitro

Bare, D.J.; Lauder, J.M.; Maness, P.F., 1992:
P59-fyn tyrosine kinase in growth cones and axonal tracts of the developing rat brain

Kelly, R.; Masurekar, P.S.; Register, E.A., 1998:
P5C reductase gene from Zalerion arboricloa

Haskard, D.O.; Mchale, J.; Harari, O.; Marshall, D., 1998:
P6 Imaging vascular activation

Hoffman, T.S.; Hu, S.; Stritzel, R.; Chandler, A., 1995:
P6 acupressure reduces nausea and gastric tachyarrhythmia provoked by optokinetic rotation

Hu, S.; Stritzel, R.; Chandler, A.; Stern, R.M., 1995:
P6 acupressure reduces symptoms of vection-induced motion sickness

Dundee, J.W.; Ghaly, R.G.; Mckinney, M.S., 1989:
P6 acupuncture anti emesis comparison of invasive and non invasive techniques

Dundee, J.W.; Yang, J., 1990:
P6 acupuncture antiemesis in cancer chemotherapy comparison of needling and percutaneous electrical stimulation

Bogdan, J.A.; Murphy, T.F.; Apicella, M.A., 1990:
P6 and the immune response to haemophilus influenzae infections

Folkman, N.; Kotler, M., 1994:
P6-Pol involves in the regulation of human immunodeficiency virus type 1 protease

Rajapandi, T.; Greene, L.E.; Eisenberg, E., 1998:
P60 is not required for formation of the active Hsp90-glucocorticoid receptor complex

Li, Y.M.; Banerjee, D.; Wojciechowicz, D.; Gilmore, R.; Vlassara, H., 1994:
P60 receptor for advanced glycosylation endproducts is identical to a subunit of oligosaccharyltransferase, OST-48

Jones, S.M.; Crosby, J.R.; Howell, K.E., 1992:
P62 Is associated with TGN38 in a phosphorylation dependent manner

Vadlamudi, R.K.; Joung, I.; Shin, J., 1997:
P62 a new class of ubiquitin binding protein binds to RNA and associates with active ribosomes

Vadlamudi, R.K.; Joung, I., 1996:
P62, a phosphotyrosine independent ligand of p56Lck SH2 domain interacts with ubiquitin

Jones, S.M.; Crosby, J.R.; Howell, K.E., 1993:
P62-A cytosolic protein essential for vesicular budding-is a protein kinase

Gu, X.; Coates, P.J.; Boldrup, L.; Nylander, K., 2008 :
p63 contributes to cell invasion and migration in squamous cell carcinoma of the head and neck

Bourne, T.David.; Bellizzi, A.M.; Stelow, E.B.; Loy, A.H.; Levine, P.A.; Wick, M.R.; Mills, S.E., 2008:
p63 Expression in olfactory neuroblastoma and other small cell tumors of the sinonasal tract

Grisanzio, C.; Signoretti, S., 2007:
p63 in prostate biology and pathology

Atkinson, M.A.L.; Shiroo, M., 1990:
P65 1 plastin isolated from human peripheral blood mononuclear cells is a pointed end f actin binding protein

Popoli, M., 1993:
p65-Synaptotagmin: a docking-fusion protein in synaptic vesicle exocytosis?

Sott, C.; Belka, C.; Kiehntopf, M.; Lamping, N.; Baeuerle, P.; Herrmann, F.; Brach, M.A., 1994:
P65/relA is part of the NF-jun transcription factor complex and regulates c-jun gene expression in myelogenous leukemia cells

Uhlinger, D.J.; Taylor, K.L.; Lambeth, J.D., 1994:
P67-phox enhances the binding of p47-phox to the active NADPH-oxidase complex

Grogan, A.; Wientjes, F.; Reeves, E.; Segal, A.W., 1996:
P67-phox, p47-phox and p40-phox in the cytosol of neutrophils are predominately not associated with the assembled cytoskeleton

Gilfillan, A.J.; Warner, J.P.; Brock, D.J.H., 1997:
P67L A mutant cystic fibrosis allele with dominant mild effects

Jensen, E.D.; Niu, L.; Caretti, G.; Nicol, S.M.; Teplyuk, N.; Stein, G.S.; Sartorelli, V.; van Wijnen, A.J.; Fuller-Pace, F.V.; Westendorf, J.J., 2007:
p68 (Ddx5) interacts with Runx2 and regulates osteoblast differentiation

Fields, P.E.; Alegre, M.; Gajewski, T.F., 1998:
P68 Pak activity in naive T lymphocytes is promoted by CD28 costimulation and Th1 differentiation

Haines, G.K.I.i; Zielinski, M.; Brown, T.; Panos, R.J.; Leyland, J.; Becker, S.; Kies, M.; Pelzer, H.; Radosevich, J.A., 1995:
P68 and PCNA are inversely distributed in squamous cell carcinoma of the head and neck

Blass, S.; Mejer, C.; Specker, C.; Schwochau, M.; Vohr, H.W.; Stuhlmueller, B.; Burmester, G.R., 1997:
P68 autoantigen reactive with carbohydrate epitope specific autoantibodies in rheumatoid arthritis

Gross, W.L., 1998:
P7 Airways damage Mechanisms and sequelae

Yang, X.; Groshen, S.; Zhou, L.; Press, M.F., 1998:
P7 protein expression in primary breast cancer Correlation with breast cancer recurrence

Choi, J.H.; O'connor, T.; Kang, S.; Voorhees, J.J.; Fisher, G.J., 1996:
P70 Ribosomal protein S6 kinase is activated in psoriasis

Kitakaze, M.; Minamino, T.; Ueda, Y.; Fukushima, T.; Terada, N.; Papst, P., 1998:
P70 S6 Kinase, but not MAP kinase, is activated in the preconditioned myocardium in the dog

Proud, C.G., 1996:
p70 S6 kinase: an enigma with variations

Takai, S.; Hanai, Y.; Matsushima-Nishiwaki, R.; Minamitani, C.; Otsuka, T.; Tokuda, H.; Kozawa, O., 2008:
P70 S6 kinase negatively regulates fibroblast growth factor 2-stimulated interleukin-6 synthesis in osteoblasts: function at a point downstream from protein kinase C

Seto Ohshima, A.; Karasawa, N.; Nagatsu, I.; Onozuka, M., 1997:
P70-like protein in the gerbil brain

Flotow, H.; Thomas, G., 1993:
P70-s6k substrate recognition determinants and autoinhibitory domain Inhibitory peptides

Thomas, G., 1993:
p70s6k/p85s6k: mechanism of activation, effects of rapamycin and role in mitogenesis

Bragado, M.J.lia; Groblewski, G.E.; Williams, J.A., 1996:
P70-s6k/p85-s6k are activated by CCK in isolated rat pancreatic acini

Boluyt, M.O.; Zheng, J.S.eng; Younes, A.; O'neill, L.; Crow, T., 1995:
P70/85 S6 kinase activation is required for alpha-1-adrenergic receptor stimulated hypertrophy in neonatal rat cardiac myocytes

Karapetyian, N.V.; Shubin, V.V.; Vasiliev, S.S.; Bezsmertinaya, I.N.; Tusov, V.B.; Pashchenko, V.Z., 1992:
P700-dependent variable fluorescence at 760 nm in photosystem 1 complex of cyanobacteria at 77K

Watanabe, R.; Oda, A.; Druker, B.J.; Hato, T.; Miyakawa, Y.; Hanada, M.; Watanabe, K.; Ikeda, Y., 1994:
P72syk Is involved in protein tyrosine phosphorylation induced by an anti-CD9 antibody in human blood platelets in an ADP- and GPIIb/IIIa-dependent manner

Eray, M.; Liwszyc, G.E.; Paasinen Sohns, A.; Stahls, A.; Kaartinen, M.; Andersson, L.C., 1998:
P72syk protein tyrosine kinase An early transducer of slgG-triggered apoptotic signalling in human follicular lymphoma cells

Schultheis, B.; Kraemer, A.; Hegenbart, U.; Goldschmidt, H.; Hehlmann, R., 1998:
P73 and p53 Deletions are infrequent in multiple myeloma as detected by dual-color fluorescence in situ hybridization

Díaz, R.; Peña, C.; Silva, J.; Lorenzo, Y.; García, V.; García, Jé.M.; Sánchez, A.; Espinosa, P.; Yuste, R.; Bonilla, Félix.; Domínguez, G., 2008:
p73 Isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosis

Kroiss, M.M.; Bosserhoff, A.K.trin; Vogt, T.; Bogenrieder, T.; Landthaler, M.; Stolz, W., 1998:
P73, The new p53 homologue, is not involved in the pathogenesis of cutaneous malignant melanomas

Soond, S.M.; Barry, S.P.; Melino, G.; Knight, R.A.; Latchman, D.S.; Stephanou, A., 2008:
p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1

Van Der Zee, C.E.E.M.; Ross, G.M.; Riopelle, R.J.; Hagg, T., 1996:
P75 NGF receptor blocking prevents developmental death of cholinergic basal forebrain neurons in vivo

Menter, D.G.; Herrmann, J.L.; Nicolson, G.L., 1995:
P75 Neurotrophin receptor-mediated trophism as a malignant melanoma cell survival mechanism

Chao, M.V.; Hempstead, B.L., 1995:
p75 and Trk: a two-receptor system

Vazquez, E.; San José, I.; Naves, J.; Vega, J.A.; Represa, J., 1996:
p75 and Trk oncoproteins expression is developmentally regulated in the inner ear of human embryos

Brennan, C.; Phillips, H.S.; Landis, S.C., 1996:
P75 expression affects the NGF dependency of sympathetic neuron survival in transgenic mice

Van Der Zee, C.E.E.M.; Ross, G.M.; Riopelle, R.J.; Hagg, T., 1995:
P75 inhibition and knock-out effects on adult cholinergic forebrain neurons

Barnett, D.; Grainger, V.; Storie, I.; Dewsnap, G.; Buckley, G.A.; Reilly, J.T., 1991:
P75 interleukin 2 receptor expression in acute and chronic leukemias relevance to clinical treatment with recombinant il 2

Ylä-Kotola, T.M.; Kauhanen, M.Susanna.C.; Asko-Seljavaara, S.L.; Haglund, C.H.; Tukiainen, E.; Leivo, I.V., 2007:
P75 nerve growth factor receptor is expressed in regenerating human nerve grafts

Khursigara, G.; Chao, M.V., 1998:
P75 neurotrophin receptor interacts with Traf-6

Suzuki, K.; Tanaka, M.; Watanabe, N.; Saito, S.; Nonaka, H.; Miyajima, A., 2008:
p75 Neurotrophin receptor is a marker for precursors of stellate cells and portal fibroblasts in mouse fetal liver

Kume, T.; Nishikawa, H.; Tomioka, H.; Maeda, T.; Kaneko, S.; Akaike, A., 1998:
P75 neurotrophin receptor-mediated neuroprotection of NGF against glutamate neurotoxicity in cortical cultures

Mount, H.T.J.; Friedman, W.J.; Huber, L.J.; Chao, M.V.; Ibanez, C.F.; Dreyfus, C.F.; Black, I.B., 1994:
P75, the low affinity neurotrophin receptor, mediates effects of NGF on cultured Purkinje cell number

Dreyfus, C.F.; Aibel, L.S.; Horn, J.; Huber, L.J.; Chao, M.V.; Black, I.B., 1994:
P75, the neurotrophin receptor, mediates actions of NGF but not BDNF in basal forebrain cultures

Schor, N.F., 1996:
P75-Binding is necessary and sufficient for the anti-apoptosis effects of NGF on neuroblastoma cells

Zaborszky, L.; Ermita, B.R.; Allen, M.T.; Criminals, C.; Gluck, M., 1998:
P75-NGF immunocytochemical identification of cholinergic neurons in the rabbit basal forebrain

Conti, G.; Baron, P.; Scarpini, E.; Prat, E.; Scarlato, G., 1995:
P75-NGFR expression in peripheral neuropathies

Kahle, P.; Barker, P.; Trzeciak, A.; Weskamp, G.; Shooter, E.; Hertel, C., 1994:
P75-NGFR modulates TRK kinase activity, but not ligand internalization

Marmorstein, A.D.; Bonilha, V.L.; Yeaman, C.; Finnemann, S.; Rodriguez Boulan, E., 1997:
P75-NTR is sorted apically in RPE cells independent of the maturation of the apical surface

Morshead, C.M.; Van Der Kooy, D., 1997:
P75-receptor expression is necessary for the full complement of EGF-responsive stem cells in the adult mammalian forebrain

Stanford, L.; Ward, N.L.; Brown, R.E.; Hagg, T., 1998:
P75NGFR-deficient mice show faster learning but decreased working memory in Hebb-Williams Maze

Dougherty, K.D.; Milner, T.A., 1998:
P75NTR immunoreactive terminals differentially innervate hilar neuropeptide Y and parvalbumin interneurons

Hong, Y.; Barker, P.; Leblanc, A.C., 1997:
P75NTR induced by amyloid beta peptide 1-40 and 1-42 in primary human neuron cultures

Luther, T.; Bierhaus, A.; Maennel, D.N., 1996:
P75TNF receptor is essential for LPS-induced leucostasis

Nachman, P.H.; Falk, R.J.; Jennette, J.C., 1998:
P8 Renal damage Mechanisms and sequelae

Kinney, M.C.; Greer, J.P.; Kadin, M.E.; Decouteau, J.F.; Collins, R.D., 1996:
P80-NPM/A-LK expression in Ki1+ lymphomas Histologic and immunophenotypic correlation

Kim, Y.S.ng; Sonn, C.H.e; Whang, D.Y.un; Minn, D.R.e; Bothwell, A., 1995:
P815 cells deficient in LY-6 antigens are non-stimulatory in mixed leukocyte reactions

Hoover, S.K.; Inge, T.; Bear, H.D., 1990:
P815 specific cytotoxic t lymphocyte clone dependent upon tumor cell stimulation and exogenous interleukin 2 for proliferation

Gajewski, T.F.; Fallarino, F.; Boon, T., 1996:
P815 tumor-bearing mice are not systemically tolerant, and can be successfully treated by immunization with irradiated IL-12-but not B7-1-transfected tumor cells

Palestro, C.J.; Bitton, R.; Tomas, M.B.; Myssiorek, D.; Bhargava, K.K.; Baran, Y.M., 1997:
P829 A technetium-labeled peptide for imaging tumors possessing somatostatin receptors

Zhang, S.; Broxmeyer, H.E., 1998:
P85 Subunit of PI3 kinase does not bind to human FLT3 receptor, but does associate with SHP2 and a p150 tyrosyl-phosphorylated protein in hematopoietic cells

Reinhard, C.; Fernandez, A.; Lamb, N.; George, T., 1994:
P85-s6k is targeted to the nucleus and required for G-1 progression

Hoffman, G.S., 1998:
P9 Vasculitis Treatment-related morbidity and mortality

Antoniou, A.; Mellor, A.; Yeoman, H.; Scott, D.; Chandler, P.; Dyson, J., 1994:
P91A transgenic mice Model for minor histocompatibility responses, skin graft rejection and peripheral tolerance

Nabeshima, K.; Nakaseko, Y.; Yanagida, M., 1995:
P93-dis1 required for sister chromatid separation is a novel microtubule and spindle pole body associating protein

Matsuguchi, T.; Inhorn, R.C.; Carlesso, N.; Griffin, J.D., 1994:
P95-Vav is tyrosine-phosphorylated by GM-CSF, IL3, steel factor and P210-BCR/ABL, and is associated with JAK kinases in myeloid cells

Rabouille, C.; Kondo, H.; Warren, G., 1997:
P97 and NSF fusion pathways are not independent

Nishikori, S.; Yamanaka, K.; Sakurai, T.; Esaki, M.; Ogura, T., 2008:
p97 Homologs from Caenorhabditis elegans, CDC-48.1 and CDC-48.2, suppress the aggregate formation of huntingtin exon1 containing expanded polyQ repeat

Tuccari, G.; Barresi, G., 1989:
P97 in thyroid follicular tumors

Spengler, B.A.; Nikolopoulos, S.; Biedler, J.L.; Ross, R.A., 1994:
P98, a novel protein immunologically related to N-myc, characterizes human neuroblastoma S-type cells

Shu, M.A.; Zhang, X.; Harvey, M.; Shultz, G.A., 1994:
PA activity in implanting mouse embryos is affected by embryo interaction with extracellular matrix in vivo

Stevens, T.; Brough, G.H.; Rodman, D.M.; Mcmurtry, I.F.; Majack, R.A.; Schwartz, P.E., 1995:
PA endothelial cell expression of proteins which bind to cAMP response elements dependent and independent of cAMP

Nakazawa, M.; Kadowaki, S-etsu.; Watanabe, I.; Kadowaki, Y.; Takei, M.; Fukuda, H., 2008:
PA subunit of RNA polymerase as a promising target for anti-influenza virus agents

Tasse, J.R.; Muth, E.A.; Hsiao, C.; Ge, A.; Wardwell Swanson, J.; Kowal, D.M., 1996:
PA-2 Determinations of the competitive hmGluR4 antagonist MAP4 A direct comparison of GTP-gamma-S binding and forskolin-stimulated cAMP accumulation assays

Lillibridge, J.H.; Nywall, C.S.; Shawar, R.M.; Slattery, J.T., 1996:
PA-824, a nitroimidazopyran antitubercular agent Favorable pharmacokinetic parameters in mice after delivery in a novel oral formulation

Henke, A.; Rappold, G., 1993:
PA2.1 detects a TaqI polymorphism in the pseudoautosomal region

Strickland, E.; Millen, L.; Xiong, H.; Slaughter, C.A.; Thomas, P.J.; Demartino, G.N., 1998:
PA700, a proteasome activator complex, mediates unfoldase-like activities

Vodenicharova, M.S.; Stoilova, T.B.; Markova, M.D., 1993:
PAAG patterns of alcohol dehydrogenase in F-1 tomato seeds

Small, K.W.; Udar, N.; Mullen, L.; Yelchits, S., 1997:
PAC contig and transcript map of the North Carolina macular dystrophy locus

Shows, T.B.; Day, C.D.; Smilinich, N.J.; Ni, L.; Hejtmancik, J.F.; Nowak, N.J.; Dejong, P.J.; Davies, C.; Evans, G.A.; Smith, R.J.H.; Higgins, M.J., 1996:
PAC contig and transcript mapping in the 11p151 Usher syndrome type 1C locus

Cooper, P.R.; Nowak, N.J.; Higgins, M.J.; Stoehr, H.; Weber, B.; Gerhard, D.; D.J.ng, P.J.; Shows, T.B., 1996:
PAC coverage and transcript mapping of the Bests disease region

Tornøe, K.; Hannibal, J.; Giezemann, M.; Schmidt, P.; Holst, J.J., 1996:
PACAP 1-27 and 1-38 in the porcine pancreas: occurrence, localization, and effects

Li, B.; Chik, C.L.; Ho, A.K.; Karpinski, E., 1995:
PACAP Modulates the L-type calcium current in vascular smooth muscle cells

Darvish, N.; Nguyen, B.H.; Neale, E.; Russell, J.T., 1996:
PACAP activates a novel non-selective cation-channel in rat pineal cells

Teng, C.H.ien; Ke, F.C.un; Lee, M.T.ng; Liu, C.H.in; Lin, S.W.n; Hwang, J.J.uan, 1998:
PACAP acts synergistically with relaxin on gelatinase secretion from rat ovarian cells

Yaekura, K.; Yanagida, K.; Yada, T., 1998:
PACAP and GLP-1 protect islet beta-cells against Ca2+ toxicity induced by High K+a

Goodwin, R.; Black, I.B.; Dicicco Bloom, E., 1998:
PACAP and NT-3 differentially regulate tau expression and sympathetic neurogenesis

Baesler, I.; Kuhn, M.; Mueller, W.; Forssmann, W.G.org, 1993:
PACAP and VIP Effects on cultured atrial myocardiocytes

Mao, Y.K.; Cayabyab, F.S.; Wang, Y.F.; Lau, S.; Daniel, E.E.; Mcdonald, T.J.; Fox Threlkeld, J.E.T., 1996:
PACAP and VIP in canine ileum Immunohistochemical, binding and functional studies

Katsoulis, S.; Neumann, R.; Klomp, H.J.; Schmidt, A.; Schmidt, W.E.; Foelsch, U.R., 1998:
PACAP and VIP relax human colonic smooth muscle cells by no-independent pathways

Yanaihara, N., 1995:
PACAP and galanin Agonist and antagonist

Hannibal, J.; Fahrenkrug, J.; Ottersen, O.P.; Moller, M., 1998:
PACAP and glutamate is co-stored in retinal ganglion cells and nerve terminals in the suprachiasmatic nucleus of the rat A light- and electron microscopic study

Olcese, J.; McArdle, C.; Mikkelsen, J.; Hannibal, J., 1996 :
PACAP and type I PACAP receptors in the pineal gland

Yada, T.; Sakurada, M.; Ishihara, H.; Nakata, M.; Yaekura, K.; Kikuchi, M.; Oka, Y., 1997:
PACAP as an intra-islet amplifier of glucose-induced insulin secretion

Parkman, H.P.; Pagano, A.P.; Ryan, J.P., 1995:
PACAP contracts guinea pig gallbladder smooth muscle via a direct myogenic effect mediated through voltage dependent calcium channels

Ohtsuka, M.; Fukumitsu, H.; Furukawa, S., 2008:
PACAP decides neuronal laminar fate via PKA signaling in the developing cerebral cortex

Moody, T.; Hida, T.; Jakowlew, S.; Birrer, M.; Pisegna, J.; Wank, S.; Fridkin, M.; Gozes, I., 1995:
PACAP hybrid A new antagonist for PACAP receptor splice variants

Shioda, S.; Yada, T.; Nakajo, S.; Nakai, Y.; Arimura, A., 1997:
PACAP increases cytosolic calcium in vasopressin neurons Synergism with noradrenalin

Burlage, M.; Foelsch, U.R.; Schmidt, W.E., 1997:
PACAP inhibits gastrointestinal transit in the conscious rat after ICV-injection

Parkman, H.P.; Pagano, A.P.; Ryan, J.P., 1996:
PACAP inhibits pyloric muscle through PACAP/VIP receptors An effect partially mediated by nitric oxide

Zla, F.; Bitar, K.; Coy, D.H.; Moody, T.W., 1994:
PACAP inhibits the growth of non-small cell lung cancer cells

Buscail, L.; Cambillau, C.; Seva, C.; Scemama, J.L.; Robberecht, P.; Christophe, J.; Susini, C.; Vaysse, N., 1992:
PACAP is a new growth factor for the pancreatic tumoral AR4-2J cells

Yada, T.; Sakurada, M.; Ishihara, H.; Nakata, M.; Shioda, S.; Yaekura, K.; Hamakawa, N.; Oka, Y.; Kikuchi, M., 1997:
PACAP is an islet hormone acting as an autocrine/paracrine potentiator of glucose-induced insulin secretion

Heinzlmann, A.; Kirilly, E.; Meltzer, K.; Szabó, E.; Baba, A.; Hashimoto, H.; Köves, K., 2008:
PACAP is transiently expressed in anterior pituitary gland of rats: in situ hybridization and cell immunoblot assay studies

Lu, N.; Dicicco Bloom, E., 1996:
PACAP ligand and receptor expression in embryonic cerebral cortex

Liu, G.J.n; Madsen, B.W., 1997:
PACAP modulation of NMDA receptor channel activity in cultured embryonic chick cortical neurons

Wang, Z.Y.; Alm, P.; Håkanson, R., 1996:
PACAP occurs in sensory nerve fibers and participates in ocular inflammation in the rabbit

Ozawa, H.; Shioda, S.; Dohi, K.; Mizushima, H.; Matsumoto, K.; Nakajo, S.; Nakai, Y.; Arimura, A., 1997:
PACAP prevents hippocampal neuronal cell death Involvement of JNK/SAPK signaling pathway

Azuma, Y-Taka.; Hagi, K.; Shintani, N.; Kuwamura, M.; Nakajima, H.; Hashimoto, H.; Baba, A.; Takeuchi, T., 2008:
PACAP provides colonic protection against dextran sodium sulfate induced colitis

Pardi, D.; Margiotta, J.F., 1996:
PACAP receptor activation inhibits alpha-7-containing neuronal acetylcholine receptors

Zia, F.; Leyton, J.; Coelho, T.; Bitar, K.; Coy, D.; Moody, T., 1997:
PACAP receptors are present on breast cancer cell lines

Mccune, S.K.; Spong, C.Y.; Brenneman, D.E.; Hill, J.M., 1998:
PACAP receptors in the developing mouse CNS

Sayer, J.M.; Smith, J.A.; Coupland, K.; Long, R.G., 1994:
PACAP receptors in the human duodenum

Ding, J.M.; Chen, D.; Hannibal, J.; Fahrenkrug, J.; Larsen, P.; Mikkelsen, J.D.; Gillette, M.U., 1996:
PACAP resets the circadian rhythm in the suprachiasmatic nucleus via a cAMP-dependent pathway

Suh, J.; Lu, N.; Dicicco Bloom, E., 1998:
PACAP signaling in vivo regulates cerebral cortex neurogenesis

Foresta, C.; Nogara, A.; Gottardello, F.; Bordon, P.; Rossato, M., 1997:
PACAP stimulates Leydig cell steroidogenesis through a novel mechanism of action

Gonzalez, B.J.; Vaudry, D.; Basille, M.; Anouar, Y.; Fournier, A.; Vaudry, H., 1997:
PACAP stimulates c-fos gene expression and promotes cell survival in rat cerebellar granule cells through activation of the protein kinase A pathway

Rawlings, S.R.; Demaurex, N.; Schlegel, W., 1994:
PACAP stimulates calcium and potassium currents in rat pituitary gonadotrophs

Ohning, G.V.; Curi, A.; Lyu, R.M.; Zeng, N.; Wong, H.C.; Sachs, G.; Walsh, J.H.; Pisegna, J.R., 1998:
PACAP stimulates gastric acid secretion during somatostatin immunoneutralization in rats

Ahren, B.; Filipsson, K.; Pacini, G., 1997:
PACAP stimulates insulin secretion but reduces insulin sensitivity in mice

Lee, S.T.; Lee, K.Y.; Chang, T.M.; Coy, D.; Chey, W.Y., 1995 :
PACAP stimulates pancreatic secretion via the release of secretin and cholecystokinin in rat

Sahye, U.; Holdstock, J.G.; Burrin, J.M., 1994:
PACAP stimulates transfected glycoprotein hormone alpha-gene expression in clonal pituitary gonadotrophs

Rawlings, S.R., 1994:
PACAP, PACAP receptors, and intracellular signalling

Tornoe, K.; Hannibal, J.; Fahrenkrug, J.; Holst, J.J.ul, 1997:
PACAP- as neurotransmitter in pig pancreas Receptor activation revealed by the antagonist PACAP-

Barnhart, D.C.; SarosiGeorge, A.Jr.; Mulholland, M.W., 1996:
PACAP-38 activates both cyclic AMP and calcium signaling pathways in rat acinar cell line

Journot, L.; Villalba, M.; Bockaert, J., 1997:
PACAP-38 protects cerebellar granular cells from potassium withdrawal-induced apoptosis through activation of protein kinase A and MAP kinase pathways

Tornoe, K.; Hannibal, J.; Giezemann, M.; Holst, J.J., 1994:
PACAP-38-occurrence, localization, release and effects in porcine pancreas

Schaefer, H.; Zheng, J.; Guenther, R.; Gundlach, F.; Schmidt, W.E., 1995:
PACAP-induced growth of rat pancreatic acinar tumor cells involves increased expression of cfos and cjun and activation of the AP1 transcription factor-complex

Tanaka, K.; Shibuya, I.; Kanno, T., 1995:
PACAP-induced increase in -c and catecholamine secretion in bovine adrenal chromaffin cells

Grider, J.R., 1997:
PACAP-induced stimulation of VIP release from gastric myenteric neurons is mediated by post-junctional release of NO

Zhong, Y., 1995:
PACAP-like neuropeptide transmission mediated by coactivation of Ras/Raf and cAMP signal transduction pathways in Drosophila

Carmena, M.J.; Solano, R.M.; Guijarro, L.G.; Prieto, J.C., 1996:
PACAP-preferring receptors in human hyperplastic prostate

Aylwin, S.J.B.; Holdstock, J.G.; Burrin, J.M., 1996:
PACAP-responsive regions in the pituitary alpha-subunit promoter

Taylor, J.E., 1996:
PACAP-type IB receptors mediate stimulation of phosphoinositide metabolism in mouse neuroblastoma cells, clone N1E-115

Hezareh, M.; Journot, L.; Bépoldin, L.; Schlegel, W.; Rawlings, S.R., 1996:
PACAP/VIP receptor subtypes, signal transducers, and effectors in pituitary cells

Cavallaro, S.; Musco, S.; D'agata, V.; Arimura, A.; Nuciforo, G.; Ricciardolo, F.; Petralia, S.; Travali, S.; Canonico, P.L.; Stivala, F., 1996:
PACAP/VIP receptors in human prostate

Inagaki, N.; Kuromi, H.; Seino, S., 1996:
PACAP/VIP receptors in pancreatic beta-cells: their roles in insulin secretion

Kantor, O.; Molnar, J.; Arimura, A.; Koves, K., 1998:
PACAP1-38, but not PACAP1-27 or VIP, blocks the ovulation in rats

Yada, T., 1993:
PACAP27 at 10-13 M increases cytosolic free calcium in rat islet beta-cells leading to insulin secretion

Lyles, J.M.; Weill, C.L.; Arimura, A., 1992:
PACAP27 induces transcription of immediate early genes in PC12 cells

Kobayashi, H.; Uezono, Y.; Izumi, F., 1994:
PACAPs increase cAMP in rat cerebral microvessels

Granato, Paul, A., 1994:
PACE A magnetic bead assay for the noncultural diagnosis of gonorrhea

Norris, S.L.; Pratt, M.; Buchner, D.M.; Wagner, E.H.; Grothaus, L.C., 1998:
PACE effectiveness in a managed care setting

Engels, E.A.; Spitz, M.R., 1997:
PACE-setting research

Linch, D.C.; Hudson, G.V.ughan; Hudson, B.V.ughan; Anderson, L., 1994:
PACEBOM is superior to CHOP in patients with Stage IV histologically aggressive non-Hodgkins lymphoma Results of a British National Lymphoma Investigation Trial

Minato, Kotaro, 1995:
PACS and information highway

Haufe, G.; Jakob, R.; Northrup, S., 1996:
PACS at work A multimedia E-mail tool for the integration of images, voice and dynamics annotation

Larsson, E.M.; Holtas, S.; Lonntoft, M.; Svahn, G.; Ehn, A.; Bengtsson, E., 1992:
PACS for improvement of neuroradiology conferences

Starkschall, George, 1994:
PACS for radiotherapy

Wan, L.; Molloy, S.S.; Thomas, L.; Liu, G.; Xiang, Y.; Rybak, S.L.; Thomas, G., 1998:
PACS-1 defines a novel gene family of cytosolic sorting proteins required for TGN localization

Passariello, R.; Politi, C.; Caramella, D.; Giribona, P.; Baleriaux, D.; Hernando, P.; Carreno, J.; Micheli, L.; D.C.rtaines, J.; Florin, C., 1992:
PACS-IMACS Operation evaluation and basic requirements for prospective evolution of PACS technology

Cousin, Hélène.; Desimone, D.W.; Alfandari, D., 2008:
PACSIN2 regulates cell adhesion during gastrulation in Xenopus laevis

Walley, T., 1993:
PACTLINE A program to allow practical utilisation of PACT data

Manjarrez, E.; Enriquez, E.; Rudomin, P., 1995:
PAD and presynaptic inhibition elicited in group Ia muscle afferents persist 1-3 months after crushing their axons in the peripheral nerve

Angel, M.J.; Mccrea, D.A.; Fyda, D.; Shefchyk, S.J., 1992:
PAD of perineal afferents evoked by stimulation of sensory afferents and during micturition in the cat

Enriquez, M.; Jimenez, I.; Rudomin, P., 1992:
PAD patterns of regenerated group I afferents after peripheral nerve crush in the cat

An, F.Y.; Wu, K.; Clewell, D.B., 1997:
PAD1 of Enterococcus faecalis confers a clumping response to subinhibitory concentrations of chloramphenicol, tetracycline and erythromycin

Hohnloser, Joerg, H., 1993:
PADS A computerized patient record

Qu, X.W.; Rozenfeld, R.A.; Huang, W.; Hsueh, W., 1997:
PAF Induces xanthine dehydrogenase conversion to xanthine oxidase in rat intestine Relevance for intestinal necrosis

Matsuzaki, M.; Ishiguro, Y.; Tetsumoto, T.; Tsukada, Y.; Kayahara, H.; Tadasa, K., 1992:
PAF acetylhydrolase activities in human systemic lupus erythematosus and lupus-prone mice

Arai, H.; Hattori, M.; Adachi, H.; Hattori, K.; Tsujimoto, M.; Inoue, K., 1994:
PAF acetylhydrolase as novel calcium-independent phospholipase

Hough, S.R.; Parks, J.E., 1995:
PAF acetylhydrolase from bovine seminal plasma utilizes sn-2 short-chain choline phospholipids

Keizo, I.; Hiroyuki, A.; Mitsuharu, H., 1994:
PAF acetylhydrolase from mammalian tissues

D.P.aen, I.; Tan, X.D.; Chang, H.; Hsueh, W., 1997:
PAF activates NF-kappa-B in small intestinal epithelial cells in rats

Foster, A.P.; Mccabe, P.; Sanjar, S.; Cunningham, F.M., 1994:
PAF and LTB-4 prime interleukin-5-induced equine eosinophil adherence, but eosinophils from horses with allergic skin disease do not exhibit enhanced adhesive properties

Sterner Kock, A.; Braun, R.K.; Hyde, D.M., 1995:
PAF and TNF-alpha synergistically increase neutrophil adherence to, and expression of ICAM-1 and E-selectin on endothelial cells in vitro

Denizot, Y.; Charissoux, J.L.; Nathan, N.; Praloran, V., 1995:
PAF and haematopoiesis: V. Platelet-activating factor and acetylhydrolase in human femoral bone marrow

Pretolani, M.; Vargaftig, B.B.ris, 1993:
PAF and interleukin-5 in experimental lung hyperresponsiveness

Klabunde, R.; Carson, N., 1998 :
PAF and no mediated macromolecular leakage in the hamster cheek pouch microcirculation

Mcintyre, T.M.; Zimmerman, G.A.; Prescott, S.M., 1996:
PAF and novel inflammatory phospholipids

Izzo, A.A., 1996:
PAF and the digestive tract. A review

Crawford, S.E.; Huang, L.J.; Hsueh, W.; Takami, H.; Crussi, F.G.; Backer, C.L.; Liu, H.; Mavroudis, C., 1994:
PAF antagonist and captopril prevent intimal proliferation in experimental graft coronary artery disease Role of endogenous PAF

Lo, C.; Garcia, I.; Maier, R.V., 1994:
PAF antagonist, CV3988, inhibits TNF production by LPS stimulated alveolar macrophages

Handley, D.A.; Cerasoli, F., J., 1994:
PAF antagonists as asthma therapeutics

Moore, T.M.; Khimenko, P.L.; Wilson, P.S.; Pitts, V.H.; Taylor, A.E., 1996:
PAF antagonists attenuate I-R-induced microvascular injury in the isolated rat lung

Lee, W.S.; Park, K.H.; Jung, J.S.; Hong, K.W., 1997:
PAF antagonists inhibit leukocyte infiltration and inducible nitric oxide synthase in rat brain following transient cerebral ischemia

Louis, R.; Bury, T.; Corhay, J.L.; Weber, G.; Radermecker, M.F., 1993:
PAF enhancement of histamine release from human leukocytes

Tan, X.; Gonzalez Crussi, F.; Hsueh, W., 1994:
PAF enhances the activities of AP-1 and AP-2 in rat intestine

Kurose, I.; Granger, D.N.il, 1994:
PAF in ischemia and reperfusion Effects on the microvasculature

D.B.issieu, D.; Denizot, Y., 1992:
PAF in stools of children Correlations with gut inflammatory states

Gonzalez Crussi, F.X.; Tan, X.; Sun, X.; Fuentes Martinez, M.; Hsueh, W., 1993:
PAF increases group II phospholipase A2 gene expression and enzyme activity in rat intestine

Tao, Y.; Bazan, H.E.P.; Decoster, M.A.; Bazan, N.G., 1996:
PAF induces cyclooxygenase gene expression in the corneal epithelium partially by a receptor-mediated calcium influx

Sun, X.M.; Tan, X.D.; Hsueh, W., 1997:
PAF induces gene expression of 5-lipoxygenase-activating protein in rat intestine

Qu, X.W.; Tan, X.D.; Mckendrick, W.; Huang, W.; Caplan, M.S.; Hsueh, W., 1995:
PAF induces intestinal iNOS in rats

Catalan, R.E.; Martinez, A.M.; Aragones, M.D.; Fernandez, I.; Miguel, B.G.; Calcerrada, M.C.; Perez, M.I., 1993:
PAF is involved in endothelin-stimulated phosphoinositide turnover

Toledano, B.; Bastien, Y.; Mazer, B., 1997:
PAF modulates oxidative stress in alpha-IgM mediated apoptosis in RAMOS B lymphoblasts

Lear, C.; Mcmanus, L.; Mealey, B.; Pinckard, R.; Powell, C.; Woodard, D., 1995:
PAF molecular heterogeneity in oral inflammation Quantitation by mass spectrometry

Mcmanus, L.M.; Bloodworth, R.C.; Deavers, S.I., 1995:
PAF molecular species-dependent cardiovascular alterations

Parker, M.A.; Decoster, M.A.; Bazan, N.G., 1998:
PAF potentiates NMDA-induced release of reactive oxygen species from mitochondria to neuronal cytosol

Kruse Elliott, K.T.; Chaban, K.; Darien, B.J.; Kamke, C.; Tomasko, S., 1996:
PAF priming of porcine neutrophil superoxide release is inhibited by low molecular weight heparin

James, H.; Perry, S.W.; Epstein, L.G.; Gelbard, H.A., 1997:
PAF receptor expression in HIV-1

Tan, X.D.; Chang, H.; Caplan, M.; Mackendrick, W.; Hsueh, W., 1997:
PAF regulates mucosal barrier function of rat small intestine Possible role of tyrosine phosphorylation of E-cadherin

Hassan, G.; Boutin, C.; Bkaily, G., 1998:
PAF stimulates the R-type channel and increases c and n in human vascular cells

West, R.R.; Van, N., J.; Varming, A.R., 1996:
PAF synthesis modulators

Wang, H.; Tan, X.D.; Qu, X.W.; Chang, H.; Hsueh, W., 1997:
PAF upregulates plasma and tissue PAF acetyl-hydrolase activities in the rat

Bourgain, R.H.; Andries, R.; Esanu, A.; Braquet, P., 1992:
PAF-acether induced arterial thrombosis and the effect of specific antagonists

Menez, J.F.; Bidault, J.; Thomas, Y.; Benveniste, J., 1993:
PAF-acether levels in blood and liver of rats after acute and chronic administration of ethanol

E.A.zouzi, B.; Jurgens, P.; Benveniste, J.; Thomas, Y., 1993:
PAF-acether modulates apoptosis in an immature T cell line

Karasawa, K.; Satoh, N.; Setaka, M.; Nojima, S., 1994:
PAF-acetylhydrolase activities accumulate in the peritoneal cavity after E coli LPS administration

Karabina, S.A.P.; Liapikos, T.A.; Grekas, G.F.; Goudevenos, J.A.; Tselepis, A.D., 1994:
PAF-acetylhydrolase activity in human LDL subfractions before and after oxidative modification in vitro

Hough, S.R.; Parks, J.E., 1997:
PAF-acetylhydrolase in bovine seminal plasma is produced by the vesicular glands and has sequence homology with PAF-AH from human blood

Kertscher, H.P.; Schwabe, W.; Grupe, R., 1993:
PAF-antagonists with phospholipid structure Part 5 Propanediol phospholipids with various substituted pyridinium and quinuclidinium head groups and variation of the P-N-distance Synthesis, characterization and structure-activity relationships

Koltai, M.; Pirotzky, E.; Braquet, P., 1994:
PAF-cytokine autocatalytic feed-back network in septic shock Involvement in acute failure

Zeng, S.; Guo, H.G.i, 1998:
PAF-induced P-selectin expression in platelets and its related signal transduction

Fukunaga, K.; Ohmitsu, M.; Miyamoto, E., 1995:
PAF-induced activation of CaM kinase II and MAP kinase in cultured rat hippocampal neurons

Kantak, S.S.; Jones, C.L.; Singh, B.; Bossung, D.E.; Onoda, J.M., 1994:
PAF-induced alteration of morphology, cytoskeletal organization and ICAM-1 receptor expression in microvascular endothelial cell monolayers

Koltai, M.; Hosford, D.; Braquet, P., 1993 :
PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists

Perretti, F.; Manzini, S., 1992:
PAF-induced bronchial hyperresponsiveness in anaesthetized guinea pigs is dependent upon capsaicin-sensitive mechanism

Whelan, C.J.; Hughes, S.C.; Vardey, C.J., 1994:
PAF-induced eosinophilia, but not LPS-induced neutrophilia, in guinea-pig lung is mediated by IL-5

Casadevall, M.; Panes, J.; Benoit, J.; Pique, J.M.; Granger, D.N., 1995:
PAF-induced leukocyte adherence is depressed in mesenteric venules with portal hypertension

Meadows, R.L.; Bloodworth, R.; Mcmanus, L.M., 1996:
PAF-induced pulmonary eosinophil recruitment in the rabbit

Chami, O.; Ott, T.; Bazer, F.W.; O'neill, C., 1998:
PAF-induced uterine PGF2alpha release is inhibited by interferon tau and responsiveness by the uterus to PAF occurs spontaneously at approximately 6 hourly intervals

Haapaniemi, H.; Tomita, M.; Fukuuchi, Y.; Tanahashi, N.; Takeda, H.; Terakawa, S., 1993:
PAF-induced white cell-endothelial cell interactions observed under a VEC microscope

Yavin, E.; Kunievsky, B.; Gil, S., 1995:
PAF-mediated thromboxane production in pathophysiology of fetal brain ischemia

Chen, M.E.; Sikes, R.A.; Troncoso, P.; Lin, S.H.a; Von Eschenbach, A.C.; Chung, L.W.K., 1996:
PAGE and GAGE-7 are novel genes expressed in the LNCAP prostatic carcinogenesis model that share homology with melanoma associated antigens

Mossman, D.; Vandermeulen, J.H., 1996:
PAH bile-metabolites in winter flounder from a coal-tar contaminated estuary and after experimental exposure to contaminated sediments in the laboratory

Burnison, B.K.; Nuttley, D.J., 1996:
PAH binding to organics present in natural waters and pulp mill effluents

Pritchard, P.H., 1995:
PAH bioremediation; importance of surfactants, inoculation and co-metabolism

Lee, W.J.y; Wang, Y.F.n; Lin, T.C.ang; Chen, Y.Y.an; Lin, W.C.ang; Ku, C.C.uen; Cheng, J.T.ng, 1995:
PAH characteristics in the ambient air of traffic-source

Marshall, K.R.; Coull, B.C., 1996:
PAH effects on removal of Meiobenthic copepods by juvenile spot

Li, C.T.h; Lee, W.J.y; Mi, H.H.uan; Su, C.C.ing, 1995:
PAH emission from the incineration of waste oily sludge and PE plastic mixtures

Li, C.T.h; Lee, W.J.y; Wu, C.H.; Wang, Y.T.ng, 1994:
PAH emission from waste ion-exchange resin incineration

Kelly, C.; Law, R.J.; Baker, K.L.; Lunn, M.M.E.; Mellor, P.K., 2008:
PAH in commercial shellfish following the grounding of the MSC Napoli in Lyme Bay, UK, in 2007

Kuljukka, T.; Rantanen, L.; Mikkonen, S.; Peltonen, K.; Savela, K., 1998:
PAH metabolism and DNA adducts formed by diesel fuel emissions analyzed in human MCF-7 cell line and in in vitro

Dowling, T.C.; Frye, R.F.; Matzke, G.R.; Fraley, D.S., 1997:
PAH renal clearance after an IV bolus is not an accurate marker of ERPF

Khalili, N.R.; Scheff, P.A.; Holsen, T.M., 1995:
PAH source fingerprints for coke ovens, diesel and gasoline engines, highway tunnels, and wood combustion emissions

Corrigan, G.; Kwon, O.; Dafoe, D.; Alfrey, E.; Sommer, G.; Scandling, J.D.; Myers, B.D., 1998:
PAH transport and blood flow in post-ischemic, acute renal allograft failure

Dantzler, W.H.; Evans, K.; Wright, S.H., 1994:
PAH uptake and efflux in isolated rabbit proximal renal tubules Kinetics and inhibition

Lin, Y.; Cai, L-Xi., 2008:
PAH-degrading microbial consortium and its pyrene-degrading plasmids from mangrove sediment samples in Huian, China

Caricchia, A.M.; Chiavarini, S.; Creminsini, C.; Martini, F.; Morabito, R., 1993:
PAHS, PCBs, and DDE in the Northern Adriatic Sea

Mihalik, S.J.; Morrell, J.C.; Kim, D.G.; Watkins, P.A.; Gould, S.J., 1997:
PAHX is a newly identified gene which codes for the peroxisomal protein phytanoyl-CoA alpha-hydroxylase and is defective in Refsum disease

Kilgore, A.L.; Okon, S.L.; Manning, K.S.; Landry, C.A.; Effiong, R.I., 1998:
PAHs and Louisiana oyster

Tian, Y.; Liu, H.J.; Zheng, T.L.; Kwon, K.K.; Kim, S.J.; Yan, C.L., 2008:
PAHs contamination and bacterial communities in mangrove surface sediments of the Jiulong River Estuary, China

Unger, M.; Gustafsson, O., 2008:
PAHs in Stockholm window films Evaluation of the utility of window film content as indicator of PAHs in urban air

Caricchia, A.M.; Chiavarini, S.; Cremisini, C.; Fantini, M.; Morabito, R.; Perini, A.; Pezza, M., 1993:
PAHs in atmospheric particulate in the area of the Italian scientific base in Antarctica

Feng, L.; Bernhard, R.; Li, R-Dong.; Li, Y-Ji., 2008:
PAHs of source separation household organic waste and composting production

Anvari, A.; Tuerel, Z.; Gottsauner Wolf, M.; Huber, K., 1998:
PAI I gene polymorphism in patients with coronary heart disease and malignant ventricular arrhythmias

Nassiri, S.; Conrad, J.; Plu Bureau, G.; Horellou, M.H.; Elalamy, I.; Samama, M., 1998:
PAI-1 4G/5G polymorphism and deep venous thrombosis in factor V Leiden patients

Jorgensen, B.; Nielsen, J.D.lsgaard; Helligso, P.; Egeblad, M., 1996:
PAI-1 A risk factor in percutaneous transluminal angioplasty

Bronisz, A.; Rosc, D.; Kotschy, M.; Graczykowska Koczorowska, A., 1997:
PAI-1 activity in pregnants with type 1 and type 2 diabetes

Juhan Vague, I.; Alessi, M.C.ristine, 1998:
PAI-1 and the risk of cardiovascular disease

Stefansson, S.D.A.L.wrence; Argraves, W.S., 1995:
PAI-1 and vitronectin promote the cellular clearance of thrombin by members of the LDL-receptor family

Morange, P.; Alessi, M.C.; Ventura, N.; Verdier, M.; Casanova, D.; Magalon, G.; Juhan Vague, I., 1998:
PAI-1 antigen production by human adipose tissue is correlated with that of TNA alpha

Morange, P.; Alessi, M.C.; Ventura, N.; Verdier, M.; Casanova, D.; Magalon, G.; Juhan Vague, I., 1998:
PAI-1 antigen production by human adipose tissue is correlated with that of TNFalpha

Vogelsang, H.; Nekarda, H.; Angermeier, C.; Huber, F.; Roder, J.; Siewert, J.R., 1994:
PAI-1 as an independent prognostic factor in resected colo-rectal carcinoma Preliminary results

Salat, C.; Holler, E.; Kolb, H.J.; Pihusch, R.; Reinhardt, B.; Hiller, E., 1996:
PAI-1 as marker of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation A report of two cases

Bjorquist, P.; Brohlin, M.; Ehnebom, J.; Ericsson, M.; Kristiansen, C.; Pohl, G.; Deinum, J., 1994:
PAI-1 binds exclusively to the protease domain of tPA

Soff, G.A.; Senderowicz, J.; Takano, S.; Verrusio, E.; Weiss, I.; Brem, S.; Kwaan, H.C., 1995:
PAI-1 expression human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis and metastases in an athymic mouse carcinoma model

Loskutoff, David, J., 1994:
PAI-1 gene expression in health and disease

Mlynarska, A.; Witas, H.W.; Mlynarski, W.; Sychowski, R.; Szadkowska, A.; Andrzejewski, W.; Bodalski, J., 1998:
PAI-1 gene polymorphism may involved retinopathy and microalbuminuria in children with type 1 diabetes

Ye, Y.Z.; Chen, X.M.; Yu, Z.H.; Liao, H.J., 1998:
PAI-1 gene transfer promotes ECM accumulation of rat mesangial cells

Thorlacius Ussing, O.; Iversen, L.H.; Nielsen, H.J.; Okholm, M.; Ejlersen, E.; Stephens, R.W.; Brunner, N., 1997:
PAI-1 in cytosolic extracts from different parts of colorectal tumors and normal mucosa, and its relation to PAI-1 plasma levels

Nordt, Thomas, K., 1996:
PAI-1 in experimental diabetes models

Fujii, Satoshi, 1996:
PAI-1 in thrombosis and arteriosclerosis

Genser, N.; Lechleitner, P.; Maier, J.; Mair, J.; Dienstl, F.; Puschendorf, B., 1993:
PAI-1 increase after thrombolytic therapy in patients with suspected myocardial infarction

Salat, C.; Holler, E.; Kolb, H.J.; Pihusch, R.; Reinhadt, B.; Hiller, E., 1996:
PAI-1 indicates veno-occlusive disease in the differential diagnosis of hyperbilirubinemia after bone marrow transplantation

Dorta, G.; Sordat, I.; Chaubert, P.; Benhattar, J.; Saraga, E.; Protiva, P.; Blum, A.L.; Sordat, B., 1998:
PAI-1 is an indicator for adenoma recurrence after polypectomy

L.M.gueresse, B.; Pernod, G.; Kolodie, L.; Morera, A.M.; Benahmed, M., 1996:
PAI-1 is regulated by two growth factors and a cytokine in rat testicular myoid cells

Bayer, C.; Schilling, D.; Hoetzel, J.; Egermann, H.Peter.; Zips, D.; Yaromina, A.; Geurts-Moespot, A.; Sprague, L.Deborah.; Sweep, F.; Baumann, M.; Molls, M.; Adam, M., 2007:
PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neck

Testa, I.; Bonfigli, A.R.; Manfrini, S.; Gregorio, F.; Cenerelli, S.; Brugni, M.; Recanatini, A.; Testa, R., 1997:
PAI-1 plasma levels are dependent on the Lp concentration in a NIDDM population treated with metformin

Grancha, S.; Estelles, A.; Tormo, G.; Falco, C.; Gilabert, J.; Espana, F.; Cano, A.; Segui, R.; Aznar, J., 1998:
PAI-1 promoter polymorphism and elevated PAI-1 circulating levels in postmenopausal women with coronary artery disease

Carroll, V.A.; Mihaly, J.; Hufnagl, P.; Matsuda, E.; Binder, B.R., 1998:
PAI-1 regulates adhesion of fibrosarcoma cells by promoting internalisation of uPAR/uPA/PAI-1 complexes

Juhan-Vague, I.; Alessi, M.C., 1997:
PAI-1, obesity, insulin resistance and risk of cardiovascular events

Rizzo, L.; Penno, G.; Rapuano, A.; Nannipieri, M.; Cecchetti, P.; Bandinelli, S.; Pucci, L.; Bertacca, A.; Navalesi, R., 1995:
PAI-1, t-PA and albumin excretion rate in type 2 diabetic patients

Rizzo, L.; Penno, G.; Rapuano, A.; Nannipieri, M.; Miccoli, R.; Bertolotto, A.; Bandinelli, S.; Navalesi, R., 1995:
PAI-1, t-PA and microalbuminuria in type 2 diabetic patients

Gan, H.; Newman, G.; Remold, H.G., 1994:
PAI-2 enhance resistance to cytolysis of macrophages infected with Mycobacterium avium

Maurer, F.; Medcalf, R.L., 1996:
PAI-2 gene induction by tumour necrosis factor and phorbol ester requires transcriptional and post-transcriptional events

Nordengren, J.; Casslen, B.; Lecander, I., 1996:
PAI-2 is present in menstrual endometrium

Schmitz,G.H.; Cullmann,J., 2008:
PAI-OFF a new proposal for online flood forecasting in flash flood prone catchments

Macchi, L.; Clofent Sanchez, G.; Bihour, C.; Durrieu Jais, C.; Marti, G.; Nurden, P.; Nurden, A., 1996:
PAICA A procedure that takes into account internalized antibody pools when characterizing platelet-associated antibodies in ITP patients or when following the fate of humanized murine antibodies on platelets in a therapeutic context

Ikebuchi, M.; Okanoya, K., 1998:
PAIE formation in zebra finches What features are used to select mate?

Tucker, J.D.; Morgan, W.F.; Awa, A.A.; Bauchinger, M.; Blakey, D.; Cornforth, M.N.; Littlefield, L.G.; Natarajan, A.T.; Shasserre, C., 1995:
PAINT: a proposed nomenclature for structural aberrations detected by whole chromosome painting

Holly, S.P.; Blumer, K.J., 1998:
PAK-like kinases STE20 and CLA4 control actin polarity in budding yeast

Cadeddu, J.A.; Stoianovici, D.; Roberts, W.W.; Taylor, R.H.; Whitcomb, L.L.; SharpeWillian, N.Jr.; Kavoussi, L.R., 1997:
PAKY An efficient device for percutaneous access of the kidney

Bokoch, G.M., 2008:
PAK'n it in: identification of a selective PAK inhibitor

Pallas, J.A.; Paiva, N.L.; Lamb, C.J.; Dixon, R.A., 1995:
PAL-suppressed tobacco are unable to develop SAR in response to TMV infection

Yang, J.L.; Wheeler, K.T.; Capizzi, R.L., 1993:
PALA enhancement of BrdU incorporation into DNA produces increased cytotoxicity with radiation in BG-1 human ovarian cancer cells

Delap, R.; Bodurian, E.; Nazzaro, D.; Farley, E.; Veach, S., 1993:
PALA plus 5-FU in colorectal cancer Pilot clinical study of a convenient outpatient treatment regimen

Witte, R.S.; Ryan, L.M.; Schutt, A.J.; Carbone, P.P.; Engstrom, P.F., 1999:
PALA versus streptozotocin, doxorubicin, and MeCCNU in the treatment of patients with advanced pancreatic carcinoma

Chen, Z.; Nasir, A.; Lord, E.M.; Ferbel, B.; Gaspari, A.A., 1994:
PAM 212 cells stably expressing high levels of B7 antigen co-stimulate T cell proliferation but do not elicit anti-tumor immunity

Zhu, W.; Okollie, B.; Bhujwalla, Z.M.; Artemov, D., 2008:
PAMAM dendrimer-based contrast agents for MR imaging of Her-2/neu receptors by a three-step pretargeting approach

Wiwattanapatapee, R.; Carreno Gomez, B.; Malik, N.; Duncan, R., 1998:
PAMAM dendrimers as a potential oral drug delivery system Uptake by everted rat intestinal sacs in-vitro

Werner, M.; Buechi, M., 1996:
PAMIR Swiss travel industry promotes AIDS prevention

Yang, Z., 1997:
PAML: a program package for phylogenetic analysis by maximum likelihood

Albert,M.; Bittel,P.; Boller,T.; Chinchilla,D.; Lipschis,M.; Muller,K.; Felix,G., 2008:
PAMP signals and their perception by receptor kinases in plants

Grasso, F.W., 1994:
PAN II A two layer neural network model of layer IV in primary visual cortex

Grosjean, E.; Grosjean, D.; Fraser, M.; Cass, G.R., 1995:
PAN and PPN in Los Angeles air

Deschenes, G.; Doucet, A., 1998:
PAN nephrosis in Brattleboro rats

Grasso, Frank, W., 1993:
PAN-A neural network model of mammalian visual cortex receptive field and column formation

Streit, P.; Stierli, B.; Tonnes, J.; Behrmann, T.; Mcilhinney, R.A.F.; Molnar, E., 1997:
PAN-AMPA and GluR1-Flop specific monoclonal antibodies

Retsky, J.; Matusewicz, D.; Hanauer, S., 1998:
PANCA and indeterminate colitis

Cornely, O.; Weise, C.; Wiedemann, M.; Klein, R.; Berg, P.; Diehl, V.; Schrappe, M., 1993:
PANCA in HIV infection Associations with CD4-plus cell count, target proteins and Kaposis sarcoma

Seibold, F.; Klein, R.; Slametschka, D.; Weber, P.; Berg, P.; Gregor, M., 1993:
PANCA in family members of patients with ulcerative colitis and PSC

Seibold, F.; Brandwein, S.; Simpson, S.; Elson, C.O., 1996:
PANCA-like reactivity in IL-10 knockout mice

Klein, M.; Rosen, A.; Vavra, N.; Gitsch, G.; Schröck, A.; Beck, A., 1992:
PAP IV in pregnancy

Jackson, C.; Taylor, V.; Chitnarong, K.; Thompson, B.; Sam, R.; Fischer, M., 1998:
PAP testing among Cambodian refugees Barriers and facilitators

Olshen, A.B.; Wijsman, E.M., 1994:
PAP vs Monte Carlo Fitting the mixed model on a large pedigree

Benoit, P.; Papin, C.; Kwak, J.Eun.; Wickens, M.; Simonelig, M., 2008:
PAP- and GLD-2-type poly(A) polymerases are required sequentially in cytoplasmic polyadenylation and oogenesis in Drosophila

Sherman, M.E.; Mango, L.J.; Kelly, D.; Ludin, V.; Paull, G.; Copeland, C.; Solomon, D.; Schiffman, M.H., 1993:
PAPNET review of smears preceding the diagnosis of a high grade squamous intraepithelial lesion or carcinoma

Hoda, R.S.; Tahir Kheli, N.; Koss, L.G., 1997:
PAPNET screening of voided urine sediments A study of 100 cases

Desai, M., 1998:
PAPNET-Assisted screening of cervical smears Comparison with conventional manual screening

Ryan, M.; Stastny, J.; Remmers, R.; Pedigo, M.; Cahill, L.; Frable, W.J., 1996:
PAPNET-directed rescreening of cervicovaginal smears A study of 101 cases of ASCUS

Van Hoeven, K.H.; Kovatich, A.J.; Dunton, C.J., 1997:
PAPNET-directed screening of MIB-1 stained cervical smears for the detection of squamous intraepithelial lesions

Brammer, N.T.; Dunlop, J.; Lever, D.; Ennis, C., 1994:
PAPP, a 5-HT-1D receptor ligand, is not a 5-HT autoreceptor agonist or antagonist in the guinea-pig frontal cortex

Aitken, D.A.; Spencer, K.; Macri, J.N.; Anderson, R.; Connor, J.M., 1993:
PAPPA as a marker of trisomy 21 in the first trimester

Tsakiris, D.A.; Tschoepl, M.; Steiner, B.; Jaeger, K.; Marbet, G.A., 1995:
PAPTA-study Platelet activation in patients with percutaneous transluminal angioplasty

Barberger Gateau, P.; Dartigues, J.F.ancois; Commenges, D.; Gagnon, M.; Letenneur, L.; Canet, C.; Miquel, J.L.uis; Nejjari, C.; Tessier, J.F.ancois, 1992:
PAQUID An interdisciplinary epidemiologic study of cerebral and functional aging

Romaneckiene,R.; Pilipavicius,V.; Slapakauskas,V.; Romaneckas,K., 2008:
PAR and UV-B radiation affecting spring barley crop and weeds

Coletti, S.D.; Schinka, J.A.; Hughes, P.H.; Hamilton, N.L.; Renard, C.G.; Sicilian, D.M.; Urmann, C.F.; Neri, R.L., 1995:
PAR Village for chemically dependent women. Philosophy and program elements

Nierodzik, M.L.; Chen, K.; Takeshita, K.; Li, J.J.; Huang, Y.Q.; Feng, X.S.; Karpatkin, S., 1997:
PAR-1 is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis

Kaufmann, R.; Patt, S.; Kraft, R.; Kalff, R.; Nowak, G., 1998:
PAR-1-type thrombin receptors are present in human meningioma cells

Tennant, G.M.; Wadsworth, R.M.; Kennedy, S., 2007:
PAR-2 mediates increased inflammatory cell adhesion and neointima formation following vascular injury in the mouse

Erdem, A.N.; Devalaraj, M.N.; Rangnekar, V.M., 1998:
PAR-4 inhibits c-RAF activated NF-kappaB induction

Hung, T.J.ne; Kemphues, K.J., 1998:
PAR-6, PAR-3, and PKC-3, an atypical protein kinase C, may form a protein complex that is asymmetrically localized to the anterior periphery of one-cell C elegans embryos through PDZ-mediated interactions

Fruscione, M.; Carboni, G.; Guindani, F.; Macchi, M., 1996:
PARCS Image Management Software A GUI application for modeling and run-time fault-tolerance management of a DICOM PACS network

Chan, D.Kam.Yin.; Mok, V.; Ng, P.Wing.; Yeung, J.; Kwok, J.B.; Fang, Z.Ming.; Clarke, R.; Wong, L.; Schofield, P.R.; Hattori, N., 2008:
PARK2 mutations and clinical features in a Chinese population with early-onset Parkinson's disease

Xu, B.; Chiu, J.; Feng, B.; Chen, S.; Chakrabarti, S., 2008:
PARP activation and the alteration of vasoactive factors and extracellular matrix protein in retina and kidney in diabetes

Richardson, D.S.; Allen, P.D.; Kelsey, S.M.; Newland, A.C., 1998:
PARP activation is involved in drug and Fas-induced apoptosis in leukaemic cells

Jacobson, E.L.; Shieh, W.M.; Ame, J.A.; Wang, Z.Q.; Wilson, M.; Koh, D., 1998:
PARP knockout mice synthesize poly

Wang, M.; Wu, W.; Wu, W.; Rosidi, B.; Zhang, L.; Wang, H.; Iliakis, G., 2006:
PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways

Harmanci, A.Ozgun.; Sharma, G.; Mathews, D.H., 2008:
PARTS: probabilistic alignment for RNA joinT secondary structure prediction

Berglund, Erik, 1996:
PAS A 50 year review

Khoma, A.M., 1955:
PAS concentration in a collapsed lung and other organs during experimental tuberculosis

Zhulin, I.B.; Taylor, B.L.; Dixon, R., 1997:
PAS domain S-boxes in Archaea, Bacteria and sensors for oxygen and redox

Huang, J.; Zheng, H.; Curtin, K.; Rosbash, M., 1994:
PAS mediated period protein dimerization may contribute to the circadian clock mechanisms in Drosophila melanogaster

Vleming, L.J.n; Baelde, H.J.; Westendorp, R.G.J.; Daha, M.R.; Van Es, L.A.; Bruijn, J.A., 1996:
PAS positive material in glomerular deposits correlates inversely with renal function in human kidney disease

Sacchi, P.; Fiandra, P.; Verme, A.; Cauvin, E., 1994:
PAS-I, a bovine polymorphic mucin

Indu, K.N.; Sreekumar, S., 1996:
PAS-lead haematoxylin as a stain for midgut endocrine cells in larvae of Oryctes rhinoceros

Theda, C.; Morrell, J.C.; Kalish, J.; Gould, S.J., 1994:
PAS7 A gene essential for peroxisome assembly

Whitmore, D.; Sassone-Corsi, P.; Foulkes, N.S., 1998:
PASting together the mammalian clock

Zipfel, P.F.; Holst, C.; Mueller, H.J.; Bialonski, A.; Skerka, C., 1992:
PAT 133 A novel member of a class of distinct growth factor-induced genes with almost identical zinc-finger domains

Wang, X.; Watt, P.M.; Louis, E.J.; Borts, R.H.; Hickson, I.D., 1997:
PAT1 A topoisomerase II-associated protein required for maintenance of genome stability in S cerevisiae

Zheng, P.; Pimplikar, S.W., 1998:
PAT1 is involved in the trafficking of amyloid precursor protein

Levitin, F.; Weiss, M.; Hahn, Y.; Stern, O.; Papke, R.L.; Matusik, R.; Nandana, S.R.; Ziv, R.; Pichinuk, E.; Salame, S.; Bera, T.; Vincent, J.; Lee, B.; Pastan, I.; Wreschner, D.H., 2008:
PATE gene clusters code for multiple, secreted TFP/Ly-6/uPAR proteins that are expressed in reproductive and neuron-rich tissues and possess neuromodulatory activity

Kingsbury, S., 1996:
PATHOS: a screening instrument for adolescent overdose: a research note

Babur, O.; Colak, R.; Demir, E.; Dogrusoz, U., 2008:
PATIKAmad: putting microarray data into pathway context

Fedele, M.; Franco, R.; Salvatore, G.; Paronetto, M.P.; Barbagallo, F.; Pero, R.; Chiariotti, L.; Sette, C.; Tramontano, D.; Chieffi, G.; Fusco, A.; Chieffi, P., 2008:
PATZ1 gene has a critical role in the spermatogenesis and testicular tumours

Swofford, David, L., 1993:
PAUP A computer program for phylogenetic inference using maximum parsimony

Terry, P.; White, R.I., 1996:
PAVMs A pulmonologists perspective

Bagby, S.; Stein, L.; Corless, C., 1997:
PAX 2 protein expression in adult ADPKD

Knepper, P.A.; Mayanil, C.S.K.; Byrne, R.W.; Goossens, W., 1995:
PAX 3 transcription factor binds to hyaluronan

Zhu, D.; Li, Y.; Traboulsi, E.I.; Levin, A.V.; Hussels, I.E.M.umenee, 1995:
PAX 6 gene mutations in aniridia

Churchill, A.J.; Anwar, R.; Markham, A.F., 1997:
PAX 6, aniridia and Peters anomaly

Stuart, E.T.; Gruss, P., 1996:
PAX: developmental control genes in cell growth and differentiation

Tremblay, P.; Gruss, P., 1994:
Pax: genes for mice and men

Hamada, S.; Miwa, H.; Saunders, G.F., 1993:
PAX gene expression in Wilms tumors

Strachan, T.; Read, A.P., 1994:
PAX genes

Read, A.P.; Van Heyningen, V., 1994:
PAX genes in human developmental anomalies

Smith, C.A.; Mariani, B.D.; Tuan, R.S., 1993:
PAX-1 antisense disruption of chick embryonic somite patterning

Iannotti, C.A.; Smith, C.A.; Mariani, B.D.; Tobias, M.C.; Tuan, R.S., 1993:
PAX-1 gene expression in the somitic chick embryo localized by whole mount in situ hybridization

Dong, H.Y.; Browne, P.; Liu, Z.; Gangi, M., 2008:
PAX-5 is invariably expressed in B-cell lymphomas without plasma cell differentiation

Kawano, H.; Fukuda, T.; Horie, M.; Osumi, N.; Eto, K.; Kawamura, K., 1998:
PAX-6 is required for the thalamocortical pathway formation in fetal rats

Eccles, M.R.; Mcnoe, L.A.; Ward, T.A.; Brunner, H.G.; Cunliffe, H.E., 1997:
PAX2 mutation identified in a patient with renal-Coloboma syndrome and vesicoureteric reflux ; analysis of 43 patients with Coloboma and/or urogenital anomalies

Schimmenti, L.A.; Byerly, K.A.; Braddock, S.R.; Eccles, M.R.; Zhang, Y.H.a; Shim, H.H., 1997:
PAX2 mutation in a patient with coloboma-ureteral-renal syndrome

Read, A.P.; Newton, V.E.; Tassabehji, M., 1995:
PAX3 and MITF mutations in auditory-pigmentary syndromes

Markova, T.; Shevtsov, S.; Lantsov, A.; Schwartz, E., 1998:
PAX3 novel mutation in Waardenburg syndrome type 1 patients in St-Petersburg

Gerard, M.; Abitbol, M.; Delezoide, A.L.; Dufier, J.L.; Mallet, J.; Vekemans, M., 1995:
PAX3-gene expression during human embryonic development

Udupi, V.; Rajaraman, S.; West, B.; Gruss, P.; S.O.ge, L.; Greeley, G.H.Jr, 1998:
PAX4 is required for differentiation of peptide YY cells in mouse colon

Macdonald, R.E.; Hitchcock, P.F.; Wilson, S.W.; Van, D.R.t, J.T., 1994:
PAX6 gene expression in the developing and regenerating retina of teleost fish

Burrill, J.D.; Saueressig, H.; Moran, L.; Goulding, M., 1997:
PAX6 is required for the generation of EN1+ interneurons in the developing spinal cord

Cveki, A.; Kashanchi, F.; Epstein, J.; Rauchman, M.; Maas, R.; Piatigorsky, J., 1996:
PAX6, a master gene for eye development Target genes and mechanism of action

Abitbol, M.; Gerard, M.; Delezoide, A.L.; Dufier, J.L.; Mallet, J.; Vekemans, M., 1995:
PAX6-gene expression during human embryonic development

Abitbol, M.; Gerard, M.; Delezoide, A.L.; Sahly, I.; Ribeaudeau, F.; Mallet, J.; Vekemans, M.; Dufier, J.L., 1995:
PAX6-gene expression during human embryonic development at the cellular level

Schafer, B.W.; Muhlebach, S.; Perriard, J.C.aude; Bernasconi, M., 1994:
PAX7 Member of the myogenic regulatory network?

Kawakami, A.; Glover, J.C., 1998:
PAX7 expression domain discriminates commissural from non-commissural vestibulo-ocular neurons in specific rhombomeres

Eitzen, G.A.; Aitchison, J.D.; Brade, A.M.; Szilard, R.K.; Nuttley, W.M.; Smith, J.J.; Glover, J.R.; Veenhuis, M.; Rachubinski, R.A., 1993:
PAY2, a Yarrowia lipolytica gene encoding a protein essential for import of proteins into peroxisomes

Xie, X.; Boysen, M., 1997:
PAgNOR greater than 1 A new prognostic variable in glottic and oral squamous cell carcinomas

Matthews, G.J.; Schlegel, P.N.; Goldstein, M., 1995:
PAtency following vaso-epididymostomy Temporal considerations

Mundy, W.R.; Ward, T.R.; Freudenrich, T.; Shafer, T.J., 1996:
PB-2+ alters protein kinase C activity isolated from rat brain and in primary neuronal cultures

Mundy, W.R.; Shafer, T.J.; Ward, T.R., 1996:
PB-2+ both activates and inhibits protein kinase C purified from rat brain and in neuronal cell culture

Qiu, D.; Damron, F.Heath.; Mima, T.; Schweizer, H.P.; Yu, H.D., 2008:
PBAD-based shuttle vectors for functional analysis of toxic and highly regulated genes in Pseudomonas and Burkholderia spp. and other bacteria

Kovach, M.E.; Phillips, R.W.; Elzer, P.H.; Roop, R.M.; Peterson, K.M., 1994:
pBBR1MCS: a broad-host-range cloning vector

Hecht, Annabel, 1977:
PBBs one states tragedy

Metcalf, J.; Bhopal, R.; Howel, J.; Myszor, M.; James, O.F.W., 1998:
PBC Increased incidence and prevalence together with geographical variation in one UK region

Metcalf, J.; Howel, D.; Bhopal, R.; James, O.F.W., 1998:
PBC prevalence is increasing Geographic variations are probably Real

Masanaga, T.; Watanabe, Y.; Leung, P.S.C.; Kamiyasu, M.; Tsuji, K.; Aisaka, Y.; Nakanishi, T.; Kajiyama, G.; Gershwin, M.E., 1996 :
PBC-like lesion is induced and maintained by immunization with recombinant PDC-E2 BCKD-E2 hybrid molecule and lipopolysaccharide injection in neonatally thymectomized mice

Masanga, T.; Watanabe, Y.; Leung, P.S.C.; Kamiyasu, M.; Sanada, E.; Nakanishi, T.; Kajiyama, G.; Gershwin, M.E., 1995:
PBC-like lesion is induced by immunization with recombinant PDC-E2 BCOADH-E2 hybrid molecule and lipopolysaccharide injection in neonatally thymectomized mice

Maier, K.P., 1997:
PBC/PSC Natural course and long-term outcome

Srinivasan, P.; Fujioka, H.; Jacobs-Lorena, M., 2008:
PbCap380, a novel oocyst capsule protein, is essential for malaria parasite survival in the mosquito

Belknap, W.; Rockhold, D.; McCue, K., 2008:
pBINPLUS/ARS: an improved plant transformation vector based on pBINPLUS

Marsh, C.B.; Wewers, M.D.; Tan, L.C.; Rovin, B.H., 1996:
PBMC and monocytes release MCP-1 in response to Fc-gamma-R cross-linking

Guilera, M.; Forns, X.; Juan, M.; Ampurdanes, S.; Olmedo, E.; Lopez Labrador, F.X.; Vilardell, C.; Vives, J.; Sanchez Tapias, J.M.; Rodes, J., 1996:
PBMC markers in chronic HCV infection

Shimoni, A.; Marcus, H.; David, M.; Canaan, A.; Berrebi, A.; Reisner, Y., 1995:
PBMC of B chronic lymphocytic leukemia patients exhibit different engraftment capacity in human/mouse chimera according to the stage of the disease

Hourihane, J.O.; Clarke, M.C.A.; Warner, J.O.; Dean, T.P., 1996:
PBMC proliferative an cytokine responses to peanut

D.N.tto, L.A.; Grover, V.; Lamont, A.G.; Johnson, T.; Thompson, S.J., 1997:
PBMC proliferative responses to HSP65 or to HSP65-derived peptides correlate with remission or low grade of RA

Visvardis, E.E.; Tassiou, A.; Baxevanis, C.N.; Papamichail, M.; Piperakis, S., 1997:
PBMCs repair capacity to oxidative DNA damage, relation to subpopulations variation and activation of apoptosis

Kelleher Andersson, J.; Wang, Y.; Cheng, I.; Xu, H., 1998:
PBN inhibition of increased beta-amyloid aggregation

Carney, J.M.; Floyd, R.A., 1995:
PBN, DMPO, and POBN compositions and method of use thereof for inhibition of age-associated oxidation

Patel, R.C.; Sen, G.C., 1997:
PBP-1, a DSRNA-binding protein that can activate PKR

Dore, M.P.; Graham, D.Y.; Sepulveda, A.R., 1998:
PBP-D, a novel penicillin-binding protein is involved in amoxicillin resistance in Helicobacter pylori

Pharo, A.; Lenschow, E.; Ugland, K.; Spannings, M.; Kvalheim, G., 1998:
PBPC collection and plasma wash in the fenwall CS 3000 gives optimal cell conditions for over night storage and cell manipulation

Dreger, P.; Oberböster, K.; Schmitz, N., 1996:
PBPC grafts from healthy donors: analysis of CD34+ and CD3+ subpopulations

Boccadoro, M.; Omede, P.; Triolo, R.; Palumbo, A.; Argentino, C.; Bruno, B.; Frier, R.; Pileri, A., 1996:
PBPC mobilition in multiple myeloma with CY followed by G-CSF Relationship between CY dose intensity and CD34+ release

Lemaistre, C.F.; Shpall, E.J.; Turner, S.A.; Wheeler, C.A.; Yanovich, S.; Brown, R.A.; Pecora, A.L.; Davis, M.W.; Parker, W.; Glaspy, J.A., 1998:
PBPC mobilization The benefits of stem cell factor and an optimal CD34+ cell yield

Goldschmidt, H.; Hegenbart, U.; Cremer, F.; Kiel, K.; Wallmeier, M.; Hohaus, S.; Haas, R.; Moos, M., 1996:
PBPC mobilization in multiple myeloma High-dose chemotherapy plus G-CSF vs two different dosages of G-CSF during steady-state

Fraipont, V.; Sautois, B.; Baudoux, E.; Fassotte, M.F.; Jerusalem, G.; Hermanne, J.P.; Longree, L.; Schaaf Lafontaine, N.; Sondag, D.; Fillet, G.; Beguin, Y., 1998:
PBPC mobilization with G-CSF alone in patients failing with chemotherapy and G-CSF

Delforge, M.; Verhoef, G.E.G.; Hagemeijer, A.; Van Duppen, V.; Boogaerts, M.A., 1998:
PBPC mobilization with G-CSF only in a patient with early stage myelodysplasia Polyclonal progenitors are rapidly suppressed by a monoclonal population

Yan, X.Q.; Hartley, C.; Chen, Y.; Mcelroy, P.; Mcniece, J.K., 1996:
PBPC mobilized by G-CSF plus SCF provide donor engraftment for over 4 years as demonstrated by serial transplantation in mice

Yan, X.O.; Harley, C.; Mcelroy, P.; Mccrea, C.; Mcniece, I., 1995:
PBPC mobilized by rhG-CSF plus rrSCF contain long-term engrafting cells capable of cellular proliferation for over 2 years as demonstrated by serial transplantation in mice

Costa, B.; Giannaccini, G.; Lucacchini, A.; Martini, C., 1998:
PBR ligand binding sites Cysteine residue modification by NEM

Sutcliffe, J.G., 1995:
pBR322 and the advent of rapid DNA sequencing

Dhillon, S.S.; Singh, K.; Brar, B.K.; Labana, K.S.; Banga, S.K.; Gupta, M.L.; Singh, G., 1994:
PBR91 a new variety of Raya Czern and Coss

Sniecinski, I.; Nowicki, B.; Dagis, A.; Niland, J., 1997:
PBSC autografts with less than 1X10-6/kg CD34+ cells

Olivieri, A.; Offidani, M.; Ciniero, L.; Cantori, I.; Montillo, M.; Rupoli, S.; Centurioni, R.; Leoni, P., 1994:
PBSC autotransplantation followed by G-CSF in 22 patients affected by lymphoproliferative disorders

Majolino, I.; Cavallaro, A.M.; Bacigalupo, A.; Rambaldi, A.; Falda, M.; Locatelli, F.; Raimondi, R.; Pucci, G.; Mordini, N.; Barbui, T.; Locatelli, F.; Rodegheiro, F.; Irrera, G.; Indovina, A.; Valbonesi, M.; Bellavita, P.; Tassi, V.; Perotti, C.; Soli, M.; Bresolin, G., 1996:
PBSC collection in healthy donors A GITMO retrospective study

Scime, R.; Majolino, I.; Vasta, S.; Buscemi, F.; Indovina, A.; Fiandaca, T.; Pampinella, M.; Catania, P.; Cavallaro, A.M.; Caronia, G.; Santoro, A., 1995:
PBSC collection in healthy donors after mobilization with rhG-CSF

Strauss Patko, M.; Maglov, C.; Balija, M.; Minigo, H.; Ostojic, S.; Planinc Peraica, A.; Kadum Skelin, I.; Vranic Bobetic, T.; Grgicevic, D.; Jaksic, B., 1998:
PBSC collection in heavily pretreated patients with haematological malignancies

Fleming, R.; Anaissie, E.; Giralt, S.; Ippolitty, C.; Champlin, R.; Mirza, N., 1997:
PBSC does not protect against aspergillosis in allogeneic transplantation A case control study of risk and prognosis factors